clopidogrel and Acute Ischemic Stroke

clopidogrel has been researched along with Acute Ischemic Stroke in 112 studies

Research

Studies (112)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (4.46)	24.3611
2020's	107 (95.54)	2.80

Authors

Authors	Studies
Baumgartner, I; Berger, JS; Blomster, JI; Fowkes, FGR; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Mulder, H; Norgren, L; North, R; Patel, MR; Rockhold, FW	1
Cheng, Y; Ge, W; Huang, L; Shao, P; Shao, T; Xu, H; Xu, Y; Yang, D; Zhang, M	1
Bath, PM; Chang, L; Dong, Q; Feng, Y; Jiang, Y; Jing, J; Johnston, SC; Li, G; Li, H; Li, W; Li, Z; Lin, J; Liu, L; Man, H; Meng, X; Niu, S; Pan, Y; Wang, A; Wang, B; Wang, L; Wang, Y; Xie, X; Xu, A; Xu, J; Zhao, J; Zhao, X; Zhuang, X	1
Fang, W; Guo, X; Jiang, H; Jin, X; Liu, Y; Sun, P; Yu, J	1
Dhaliwal, S; Dowlatshahi, D; Hutton, B; Lun, R; Roy, DC; Zitikyte, G	1
Bath, PM; Jiang, Y; Jing, J; Johnston, SC; Li, H; Li, Y; Li, Z; Lin, J; Liu, J; Liu, L; Meng, X; Tian, X; Wang, A; Wang, F; Wang, Y; Xie, X; Zhao, X; Zuo, Y	1
Fang, S; Li, F; Li, H; Li, T; Qin, S; Zhang, S; Zhu, B; Zhu, J	1
Fu, H; Lin, J; Mao, D; Mo, Y; Wei, D	1
de Havenon, A; Easton, JD; Henninger, N; Johnston, SC; Kim, AS; Kvernland, A; Liberman, AL; Mac Grory, B; Rostanski, SK; Yaghi, S	1
De Havenon, A; Feng, W; Johnston, SC; Mac Grory, B; Piccini, JP; Poli, S; Rostanski, SK; Weiss, M; Xian, Y; Yaghi, S	1
Ali, A; Baig, S; Bell, SM; Kamarova, M; Majid, A; Monks, K; Patel, H; Redgrave, J; Wasay, M	1
Jin, A; Laskowitz, DT; Li, H; Li, J; Lin, J; Meng, X; Pan, Y; Wang, Y; Wangqin, R; Xian, Y	1
Ip, A; Lau, KK; Ng, AK; Ng, PY; Siu, CW	1
Fan, H; Li, J; Li, X; Li, Y; Liu, T; Niu, X; Ren, J; Wang, Y; Wu, X; Zhang, K	1
Fan, H; Li, J; Li, X; Li, Y; Liu, T; Ma, L; Niu, X; Ren, J; Wang, Y; Wu, X; Zhang, K	1
Bhatt, DL; Fonarow, GC; Peterson, ED; Schwamm, LH; Smith, EE; Xian, Y; Xu, H	1
Fan, Y; He, P; He, Z; Li, Z; Liang, J; Wu, Y; Zhang, L	1
Akhtar, MS; Al-Ali, AK; Al-Muhanna, FA; Al-Rubaish, AM; Alabdulali, MM; Alali, RA; Alamri, AS; Alkhamis, F; Alshehri, AM; Alsulaiman, AA; Asselbergs, FW; Claassens, DMF; Cyrus, C	1
Liu, S; Shah, J; Yu, W	1
Angiolillo, DJ; Beitelshees, AL; Cavallari, LH; David Anderson, R; Dempsey, AL; Franchi, F; Gong, Y; Gower, MN; Johnson, JA; Keeley, EC; Kerensky, RA; Kulick, N; Lee, CR; Malave, JG; McDonough, CW; Mulrenin, IR; Rossi, JS; Starostik, P; Stouffer, GA; Thomas, CD; Winget, M; Winterstein, AG	1
Katsanos, AH; Tsivgoulis, G	1
Kamouchi, M; Kimura, K; Kitazono, T; Koyama, N; Matsumaru, Y; Matsuo, H; Nakamura, M; Tsutsumi, J; Umemura, K	1
Ezer, E; Molnár, A; Molnár, T; Schrick, D; Tőkés-Füzesi, M	1
Chen, Y; Li, J; Ouyang, F; Tan, Y; Xing, S; Yu, S; Zeng, J; Zhang, J; Zhou, K	1
Jing, J; Johnston, SC; Liu, L; Meng, X; Pan, Y; Wang, A; Wang, D; Wang, Y; Zhang, X; Zhao, X	1
Harahap, AR; Harris, S; Herqutanto, H; Hidayat, R; Listyaningsih, E; Loho, T; Louisa, M; Nabilah, RA; Rambe, AS; Rasyid, A	1
Bath, PM; Cheng, J; Jiang, Y; Jin, A; Jing, J; Johnston, SC; Li, H; Li, Z; Lin, J; Liu, L; Meng, X; Pan, Y; Wang, Y; Wang, Z; Xie, X; Yang, H; Zhao, X	1
Cheng, J; Deng, X; Li, H; Ma, Y; Shi, T; Wang, X; Wu, Y; Zhang, Z; Zhu, Q	1
Hoshino, H; Kimura, K; Kitagawa, K; Minematsu, K; Okamura, S; Omae, K; Toyoda, K; Uchiyama, S; Yamaguchi, T	1
Li, D; Li, X; Ling, X; Ma, N; Wei, H; Zhao, Z	1
Li, X; Sun, Y; Tian, WJ; Wang, DL; Wang, L; Wang, RN; Xia, XS	1
Bhatt, DL; Feng, W; Fonarow, GC; Fosbøl, EL; Hannah, D; Johnson, M; Laskowitz, DT; Mac Grory, B; Maisch, L; Matsouaka, R; Peterson, ED; Schwamm, LH; Smith, EE; Xian, Y; Xu, H	1
Inaba, Y; Inoue, T; Kitahara, H; Kobayashi, Y; Shiko, Y; Tateishi, K	1
Bath, PM; Leach, M; McDermott, JH; Newman, WG; Sen, D; Smith, CJ	1
Huang, HY; Katz, AJ; Lin, FJ; Lin, SY; Sheu, JJ; Wang, CC; Wu, CH	1
Lv, J; Xie, Z; Zhao, D; Zhao, G	1
Calderone, D; Capodanno, D; Scalia, L	1
Amarenco, P; Bereczki, D; Czlonkowska, A; Diener, HC; Donovan, M; Endres, M; Gailani, D; Hankey, GJ; Kahl, A; Kasner, SE; Li, D; Lutsep, HL; Molina, CA; Ntaios, G; Perera, V; Sharma, M; Shuaib, A; Toyoda, K; Tsivgoulis, G	1
Hao, R; Li, X; Wang, L; Xia, X; Yan, Y; Zhao, X	1
Moustafa, B; Testai, FD	1
Chang, R; Liu, Y; Wu, J; Ye, Y; Zhang, X; Zhou, W	1
Cheng, Y; Li, D; Liu, H; Shao, T; Wang, H; Yang, T; Zhang, J; Zhang, T	1
Chen, M; Cheng, K; Ge, J; Huang, J; Lan, J; Li, G; Qian, J; Wang, X; Wang, Y; Wei, G; Wu, H; Xu, L; Zhang, C; Zhang, H; Zhao, X	1
Bonaffini, N; Cupini, LM	1
Amarenco, P; Bath, PM; Chen, W; Gao, Y; Han, S; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, T; Wang, Y; Yang, Y; Zhao, X	1
Gu, HQ; Jiang, Y; Li, H; Li, ZX; Liu, LP; Meng, X; Wang, CJ; Wang, YJ; Wang, YL; Yang, X; Zhang, XM; Zhao, XQ	1
Chen, X; Jiang, L; Liu, C; Su, J; Zheng, N; Zhong, J	1
Bae, HJ; Cha, JK; Cho, KH; Cho, YJ; Choi, JC; Choi, JK; Choi, KH; Gorelick, PB; Gwak, DS; Han, MK; Hong, JH; Hong, KS; Jeong, HB; Kang, CH; Kang, J; Kang, K; Kim, BJ; Kim, C; Kim, DE; Kim, DH; Kim, JG; Kim, JT; Kim, JY; Kim, WJ; Kim, YS; Kwon, DH; Kwon, JH; Lee, BC; Lee, J; Lee, K; Lee, M; Lee, SH; Lee, SJ; Norrving, B; Oh, MS; Park, H; Park, HK; Park, JM; Park, KY; Park, MS; Park, SS; Park, TH; Shin, DI; Sohn, SI; Yu, KH; Yum, KS	1
de Havenon, A; Easton, JD; Furie, KL; Henninger, N; Johnston, SC; Kim, A; Lang, AE; Mac Grory, B; Shu, L; Yaghi, S	1
Alsbrook, DL; Bhatia, K; Carr, KH; Di Napoli, M; Divani, AA; Hinduja, A; Hosseini Farahabadi, M; Jafarli, A; Ladd, LM; McCullough, LD; Ortiz Garcia, JG; Sabbagh, SY; Saver, JL	1
Chen, Y; Li, D; Liu, S; Ma, X; Zhong, P	1
Bar, M; Cernik, D; Cihlar, F; Herzig, R; Husty, J; Jura, R; Klail, T; Kocher, M; Kočí, L; Kovacova, I; Kovar, M; Mikulik, R; Nevšímalová, M; Raupach, J; Rocek, M; Sanak, D; Sedova, P; Sevcik, P; Skoloudik, D; Sramek, M; Tomek, A; Vaclavik, D; Vanicek, J; Vaško, P; Vinklarek, JF	1
Chung, CP; Lee, YC; Liao, YC; Lin, CJ	1
Bath, PM; Jiang, Y; Jing, J; Johnston, SC; Li, H; Li, Z; Lin, J; Liu, L; Meng, X; Pan, Y; Wang, A; Wang, Y; Xie, X; Xu, A; Xu, Q; Zhao, X	1
Hu, MJ; Jiang, M; Lin, YD; Yao, Q; Zhang, BY; Zhou, MK; Zhu, CR	1
Deng, L; Gong, T; He, L; Lin, Y; Luo, Y; Xia, Y; Zhang, H; Zhang, Z	1
Bultasova, L; Rohan, V; Slavik, L; Ulehlova, J	1
Je, NK; Lee, YJ	1
Chen, HS; Cui, Y; Dong, YL; Guo, LY; Han, J; Huang, SM; Jiang, CH; Li, J; Li, JY; Li, YS; Li, Z; Lin, YZ; Lu, J; Ma, GB; Nguyen, TN; Piao, XY; Shen, LY; Wan, LS; Wang, DL; Wang, EQ; Wang, J; Wang, LX; Wang, RX; Wang, WZ; Xia, L; Yang, KH; Yang, QC; Zhang, H; Zhang, L; Zhou, ZH	1
Jiang, Y; Jing, J; Li, H; Li, Z; Lin, J; Liu, L; Meng, X; Tian, X; Wang, A; Wang, Y; Xie, X; Zhang, J; Zhao, X	1
Appleton, JP; Bath, PM; Christensen, H; Dineen, RA; England, TJ; James, M; Krishnan, K; Montgomery, AA; Ranta, A; Robinson, TG; Sprigg, N; Woodhouse, LJ	1
Ge, F; Li, M; Lin, H; Shi, J; Yang, Q; Zhang, X	1
Cai, Y; Chen, Z; He, Y; Li, C; Zhang, J	1
Chang, YM; Lee, TL; Sung, PS	1
Alkhachroum, A; Ancheta, S; Asdaghi, N; Del Brutto, VJ; Dong, C; Foster, D; Gardener, H; Gordon Perue, G; Gutierrez, CM; Jameson, AM; Romano, JG; Rose, DZ; Rundek, T; Sacco, RL; Sur, NB; Yin, R; Ying, H	1
Chen, J; Chen, Y; Li, C; Li, J; Lin, Y; Wang, Y; Zhang, C; Zhang, P	1
Algarni, RA; Alshargi, O; Alshehri, S; Alshibani, M; Althagafi, AA	1
Huang, HY; Katz, AJ; Lin, FJ; Lin, SY; Wang, CC; Wu, CH	1
Dietrich, D; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Li, H; Liu, L; Meng, X; Meurer, WJ; Pan, Y; Wang, Y; Zhao, X	1
Arias, F; Benavente, L; Cadenas, M; Calleja, S; Chaviano, J; González, M; Jimenez, JM; Larrosa, D; Lopez-Cancio, E; Morales, E; Murias, E; Peña, J; Rico, M; Riesco, N; Saiz, A; Vega, P	1
Chang, WL; Chen, PL; Guo, YC; Hsu, CY; Lien, LM; Sun, Y; Sung, FC; Wang, IK; Yang, YC; Yen, TH	1
Gong, H; Lan, L; Li, M; Li, X; Pan, J; Peng, Y; Rong, X; Shen, Q; Wang, H; Zhang, X	1
Howard, G; Howard, VJ; Johnston, SC; Kamel, H; Kleindorfer, DO; Levitan, EB; Soliman, EZ; Zhang, C	1
Gilbourd, D; Kanjanapan, Y; Pranavan, G	1
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Matsumoto, M; Minematsu, K; Nagao, T; Nagata, I; Nanto, S; Nishikawa, M; Ogawa, A; Shirai, T; Tanahashi, N; Toyoda, K; Uchiyama, S; Yamagami, H	2
Kalladka, D; Rounis, E	1
Chi, NF; Chien, LN; Chiou, HY; Liu, HY	1
Dong, W; He, X; Hu, H; Kong, Y; Li, Y; Li, Z; Sun, L; Wang, C; Wang, Y; Yang, D; Zhang, J; Zhao, M	1
Ahn, SH; Han, SW; Jung, YH; Kim, J; Kim, YD; Lee, HS; Lee, JY; Lee, KY; Song, TJ	1
Filipska, K; Wiśniewski, A	1
Ang, YK; De Silva, DA; Narasimhalu, K; Tan, DSY; Tan, KB	1
Bath, PM; Xiong, Y	1
Appleton, JP; Bath, PM; Dovlatova, N; Heptinstall, S; May, J; Richardson, C; Sprigg, N	1
Feng, Q; Fu, J; Jin, X; Shan, B; Shen, R; Yu, Z; Zhou, H; Zhu, H	1
Chen, Q; Chu, W; Dong, M; Dou, L; Gao, B; Li, B; Li, J; Liu, C; Pan, Y; Song, H; Song, L; Wu, H	1
Buonanno, FS; Cao, Y; Chen, P; Fang, H; Gao, Y; Guo, YN; Lo, EH; Ning, MM; Pei, LL; Song, B; Sun, SL; Wang, XY; Wu, J; Xu, YM; Zhang, R; Zhao, L	1
Jia, Q; Jia, W; Wang, Y; Zhang, Y; Zhao, X	1
Bae, HJ; Cha, JK; Cho, KH; Cho, YJ; Choi, JC; Choi, KH; Hong, JH; Hong, KS; Kang, K; Kim, BJ; Kim, DE; Kim, DH; Kim, JG; Kim, JT; Kim, WJ; Kwon, JH; Lee, BC; Lee, HL; Lee, J; Lee, JS; Lee, KB; Lee, SJ; Park, HK; Park, JM; Park, MS; Park, SS; Park, TH; Ryu, WS; Shin, DI; Sohn, SI; Sun Oh, M; Yu, KH	1
Chitale, RV; Denny, JC; Fusco, MR; Niu, X; Patel, PD; Peterson, JF; Shannon, CN; Vimalathas, P	1
Chen, M; Dai, X; Deng, X; Fu, S; Gong, Q; He, W; Huang, L; Li, C; Luo, Q; Qiu, T; Wang, J; Wang, M; Xiao, H	1
Ishigaku, Y; Itabashi, R; Kamada, A; Maeda, T; Narumi, S; Natori, T; Oi, K; Oura, K; Shimizu, M; Terayama, Y; Tsuda, K; Yoshida, M	1
Jørgensen, NR; Rath, CL; Wienecke, T	1
Wiśniewski, A	1
Fang, W; Gou, X; Hou, K; Li, F; Li, Y; Lv, N; Xu, D	1
Cho, B; Choi, HC; Kim, SJ; Kwon, OD; Lee, EJ	1
Chitale, RV; Denny, JC; Fusco, MR; Niu, X; Patel, PD; Peterson, JF; Shannon, CN	1
Auriel, E; Gronich, N; Lavi, I; Lejbkowicz, F; Pinchev, M; Rennert, G; Saliba, W; Zoabi, Y	1
Beasley, M; Brown, TM; Cai, A; Clarkson, SA; Dillon, C; Heindl, B; Limdi, N	1
Jia, W; Li, C; Li, F; Li, J; Ma, J; Zhou, L	1
Dhaliwal, S; Dowlatshahi, D; Hutton, B; Lun, R; Roy, DC; Shorr, R; Zitikyte, G	1
Alkattan, A; Alsalameen, E	1
Bigliardi, G; Borzì, GM; Ciolli, L; Dell'Acqua, ML; Lelli, N; Maffei, S; Meletti, S; Pentore, R; Picchetto, L; Ricceri, R; Rodríguez-Villatoro, N; Rosafio, F; Sacchetti, F; Tondelli, M; Vallone, S; Vandelli, G; Vandelli, L; Zini, A	1
Chang, W; Li, L; Lin, F; Liu, H; Yin, J; Zhang, H; Zhao, Y	1
Chen, C; Hu, W; Liu, D; Liu, J; Liu, T; Luo, W; Song, J; Tao, C; Yuan, X; Zhang, C; Zhu, Y	1
Case, BC; Doros, G; Medranda, GA; Waksman, R; Weintraub, WS; Yerasi, C; Zhang, C	1
Chen, J; Gao, P; Han, M; Jia, W; Kuang, J; Peng, C; Starcevich, K; Tu, J; Wang, J; Wu, Y; Yi, Y; Yin, S; Zhang, X	1
Hoshino, H; Houkin, K; Ishida, N; Isobe, M; Kimura, K; Matsumoto, M; Minematsu, K; Naritomi, H; Okada, Y; Omae, K; Origasa, H; Sakai, N; Tanaka, K; Terayama, Y; Tomimoto, H; Tominaga, T; Toyoda, K; Uchiyama, S; Yamaguchi, K; Yamaguchi, T; Yasuda, S	1
Dong, Y; Gui, L; Jing, J; Li, H; Li, S; Li, Z; Liu, LP; Meng, X; Wang, A; Wang, D; Wang, G; Wang, YJ; Wang, YL; Zhao, XQ; Zheng, H	1
Tan, Z; Wang, W; Xiao, W; Xu, A; Yang, W; Zeng, J; Zhao, Y	1
Li, H; Liu, L; Meng, X; Wang, X; Wang, Y; Wangqin, R; Xian, Y; Zhao, X	1
Chen, H; Hou, X; Li, X; Wang, X	1

Reviews

22 review(s) available for clopidogrel and Acute Ischemic Stroke

Article	Year
Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis. JAMA neurology, 2022, 02-01, Volume: 79, Issue:2 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Humans; Ischemic Attack, Transient; Ischemic Stroke; Network Meta-Analysis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Ticagrelor	2022
Antiplatelet Use in Ischemic Stroke. The Annals of pharmacotherapy, 2022, Volume: 56, Issue:10 Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke	2022
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines. Stroke and vascular neurology, 2022, Volume: 7, Issue:5 Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor	2022
High on-treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta-analysis. Acta neurologica Scandinavica, 2022, Volume: 146, Issue:3 Topics: Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke	2022
The role of Expert review of clinical pharmacology, 2022, Volume: 15, Issue:7 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome	2022
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack. Expert review of clinical pharmacology, 2022, Volume: 15, Issue:9 Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Factor XI; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor	2022
Relationship between CYP2C192, 3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2022, Volume: 31, Issue:11 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Stroke	2022
Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies. Current neurology and neuroscience reports, 2022, Volume: 22, Issue:11 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Ticlopidine	2022
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023, Volume: 23, Issue:3 Topics: Aspirin; Atherosclerosis; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Network Meta-Analysis; Platelet Aggregation Inhibitors; Regression Analysis; Rivaroxaban; Stroke; Ticagrelor	2023
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines. Current neurology and neuroscience reports, 2023, Volume: 23, Issue:5 Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin	2023
Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis. European neurology, 2023, Volume: 86, Issue:4 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Treatment Outcome	2023
Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis. BMC neurology, 2023, Aug-14, Volume: 23, Issue:1 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Network Meta-Analysis; Platelet Aggregation Inhibitors; Stroke; Ticagrelor	2023
Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis. Cardiovascular therapeutics, 2023, Volume: 2023 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Fibrinolytic Agents; Humans; Ischemic Stroke; Network Meta-Analysis; Platelet Aggregation Inhibitors; Rivaroxaban; Ticagrelor	2023
Clinical Updates on Antiplatelet Therapy for Secondary Prevention in Acute Ischemic Stroke. Acta neurologica Taiwanica, 2023, Sep-30, Volume: 32(3) Topics: Aspirin; Cerebral Infarction; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticagrelor	2023
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and JAMA neurology, 2019, 12-01, Volume: 76, Issue:12 Topics: Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Humans; Ischemic Attack, Transient; Ischemic Stroke; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome	2019
Antiplatelet therapy for transient ischaemic attack and minor ischaemic stroke. British journal of hospital medicine (London, England : 2005), 2020, Jun-02, Volume: 81, Issue:6 Topics: Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Early Medical Intervention; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Severity of Illness Index	2020
The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review. International journal of molecular sciences, 2020, Sep-03, Volume: 21, Issue:17 Topics: Blood Platelets; Clopidogrel; Humans; Ischemic Stroke; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Secondary Prevention	2020
Antiplatelet Therapy for Transient Ischemic Attack and Minor Stroke. Stroke, 2020, Volume: 51, Issue:11 Topics: Aspirin; Clopidogrel; Drug Resistance; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Risk Assessment; Secondary Prevention; Severity of Illness Index; Ticagrelor	2020
Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention. Medicina (Kaunas, Lithuania), 2021, Jan-10, Volume: 57, Issue:1 Topics: Aspirin; Biological Availability; Clopidogrel; Drug Interactions; Drug Resistance; Humans; Ischemic Stroke; Kidney Failure, Chronic; Metabolic Syndrome; Pharmacogenomic Variants; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Assessment; Secondary Prevention; Smoking; Stroke	2021
Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis. PloS one, 2021, Volume: 16, Issue:4 Topics: Aspirin; Bayes Theorem; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Network Meta-Analysis; Platelet Aggregation Inhibitors; Ticagrelor	2021
Polymorphisms of genes related to phase-I metabolic enzymes affecting the clinical efficacy and safety of clopidogrel treatment. Expert opinion on drug metabolism & toxicology, 2021, Volume: 17, Issue:6 Topics: Acute Coronary Syndrome; Clopidogrel; Cytochrome P-450 Enzyme System; Humans; Ischemic Stroke; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide	2021
Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack. The American journal of cardiology, 2021, 08-15, Volume: 153 Topics: Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Early Medical Intervention; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Mortality; Platelet Aggregation Inhibitors; Proportional Hazards Models; Secondary Prevention; Ticagrelor	2021

Trials

30 trial(s) available for clopidogrel and Acute Ischemic Stroke

Article	Year
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial. Vascular medicine (London, England), 2022, Volume: 27, Issue:1 Topics: Clopidogrel; Humans; Internationality; Ischemia; Ischemic Stroke; Myocardial Infarction; Peripheral Arterial Disease; Ticagrelor; Treatment Outcome	2022
Ticagrelor versus Clopidogrel in The New England journal of medicine, 2021, 12-30, Volume: 385, Issue:27 Topics: Aged; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Ischemic Attack, Transient; Ischemic Stroke; Loss of Function Mutation; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Ticagrelor	2021
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack. Annals of neurology, 2022, Volume: 91, Issue:3 Topics: Aged; Alleles; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Treatment Outcome	2022
Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA neurology, 2022, Mar-01, Volume: 79, Issue:3 Topics: Aged; Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Neuroimaging; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome	2022
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA. Stroke and vascular neurology, 2022, Volume: 7, Issue:4 Topics: Brain Ischemia; Cerebral Infarction; Cholesterol, LDL; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Stroke	2022
Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III). Journal of atherosclerosis and thrombosis, 2023, Mar-01, Volume: 30, Issue:3 Topics: Acute Coronary Syndrome; Clopidogrel; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stroke; Thrombotic Stroke; Treatment Outcome	2023
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial. JAMA neurology, 2022, 08-01, Volume: 79, Issue:8 Topics: Aged; Alleles; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Treatment Outcome	2022
Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:4 Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome	2023
Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet. BMC neurology, 2022, Aug-19, Volume: 22, Issue:1 Topics: Aspirin; Benzofurans; Clopidogrel; Double-Blind Method; Humans; Internet; Ischemic Stroke; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome	2022
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2022, Volume: 31, Issue:10 Topics: Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Factor XIa; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Thromboembolism; Treatment Outcome	2022
Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point-Blinded, Noninferiority Trial. Circulation, 2023, 01-17, Volume: 147, Issue:3 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Treatment Outcome; Troponin	2023
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclero Stroke and vascular neurology, 2023, Volume: 8, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Atorvastatin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Stroke	2023
Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial: Rationale and design. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:8 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Treatment Outcome	2023
Subsequent ischemic stroke and tobacco smoking: A secondary analysis of the POINT trial. European stroke journal, 2023, Volume: 8, Issue:1 Topics: Aspirin; Clopidogrel; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Neoplasm Recurrence, Local; Platelet Aggregation Inhibitors; Smoking; Stroke; Tobacco Smoking	2023
Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA network open, 2023, 06-01, Volume: 6, Issue:6 Topics: Aged; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; East Asian People; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Ticagrelor	2023
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial. JAMA, 2023, 06-27, Volume: 329, Issue:24 Topics: Administration, Intravenous; Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2023
Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2023, 07-10, Volume: 195, Issue:26 Topics: Aspirin; Body Mass Index; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Obesity; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Treatment Outcome	2023
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia. Scientific reports, 2023, 07-20, Volume: 13, Issue:1 Topics: Acute Disease; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Quality of Life; Stroke	2023
Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke. Medicine, 2023, Sep-08, Volume: 102, Issue:36 Topics: Clopidogrel; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2023
Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. JAMA neurology, 2020, 05-01, Volume: 77, Issue:5 Topics: Aged; Aspirin; Black or African American; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention	2020
Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial. Journal of atherosclerosis and thrombosis, 2021, Feb-01, Volume: 28, Issue:2 Topics: Arteries; Arteriosclerosis; Atherosclerosis; Clopidogrel; Drug Monitoring; Female; Hemorrhage; Humans; Ischemic Stroke; Male; Middle Aged; Organ Size; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome	2021
Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial. BMC neurology, 2020, Oct-29, Volume: 20, Issue:1 Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Heterozygote; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Treatment Outcome	2020
Tirofiban combined with heparin's effect and safety in the treatment of mild to moderate acute ischemic stroke. Neurological research, 2021, Volume: 43, Issue:3 Topics: Adult; Aged; Aspirin; Clopidogrel; Female; Heparin; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome	2021
Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I. Stroke, 2021, Volume: 52, Issue:4 Topics: Aged; Blood Pressure; Clopidogrel; Double-Blind Method; Female; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Secondary Prevention; Thromboembolism	2021
Personalized antiplatelet therapy based on clopidogrel/aspirin resistance tests in acute ischemic stroke and transient ischemic attack: Study protocol of a multi-center, single-blinded and randomized controlled trial. Contemporary clinical trials, 2021, Volume: 108 Topics: Aftercare; Aspirin; Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Multicenter Studies as Topic; Patient Discharge; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke	2021
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial. Stroke, 2021, Volume: 52, Issue:11 Topics: Aged; Aspirin; Cerebral Hemorrhage; Cilostazol; Clopidogrel; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention	2021
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial. Stroke and vascular neurology, 2016, Volume: 1, Issue:2 Topics: Aged; Aspirin; China; Clopidogrel; Double-Blind Method; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2016
Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial. Stroke and vascular neurology, 2017, Volume: 2, Issue:3 Topics: Aged; China; Clopidogrel; Disease Progression; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome	2017
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. Stroke and vascular neurology, 2017, Volume: 2, Issue:4 Topics: Aged; Aspirin; China; Clopidogrel; Double-Blind Method; Dual Anti-Platelet Therapy; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome	2017
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study. Stroke and vascular neurology, 2018, Volume: 3, Issue:4 Topics: Aspirin; China; Clopidogrel; Disability Evaluation; Dual Anti-Platelet Therapy; Ischemic Stroke; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome	2018

Other Studies

60 other study(ies) available for clopidogrel and Acute Ischemic Stroke

Article	Year
Platelet Function Tests Predicting the Efficacy and Safety of Aspirin Secondary Prevention. Neurological research, 2022, Volume: 44, Issue:4 Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Stroke; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Platelet Function Tests; Secondary Prevention	2022
The Clinical Efficacy of Clopidogrel Bisulfate Tablets Combined with Olmesartan Medoxomil for Ischemic Stroke with Hypertension and the Effect of Angiotensin II Type 1 Receptor Level on Prognosis. Computational and mathematical methods in medicine, 2021, Volume: 2021 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Clopidogrel; Computational Biology; Drug Therapy, Combination; Female; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Olmesartan Medoxomil; Platelet Aggregation Inhibitors; Prognosis; Receptor, Angiotensin, Type 1; Treatment Outcome	2021
Associations of CYP2C19 and F2R genetic polymorphisms with platelet reactivity in Chinese ischemic stroke patients receiving clopidogrel therapy. Pharmacogenetics and genomics, 2022, 06-01, Volume: 32, Issue:4 Topics: Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stroke; Ticlopidine; Treatment Outcome	2022
CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study. Annals of palliative medicine, 2021, Volume: 10, Issue:12 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome	2021
Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial. Journal of the American Heart Association, 2022, Volume: 11, Issue:3 Topics: Aspirin; Blood Glucose; Clopidogrel; Humans; Hyperglycemia; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Recurrence; Stroke	2022
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel. Stroke and vascular neurology, 2022, Volume: 7, Issue:4 Topics: Acute Coronary Syndrome; Brain Ischemia; China; Clopidogrel; Hemorrhage; Hemorrhagic Stroke; Humans; Intracranial Hemorrhages; Ischemic Stroke; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Stroke; Ticagrelor	2022
Dual versus mono antiplatelet therapy in mild-to-moderate stroke during hospitalization. Annals of clinical and translational neurology, 2022, Volume: 9, Issue:4 Topics: Aspirin; Clopidogrel; Cohort Studies; Hemorrhage; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke	2022
Evaluation of the association between admission systolic blood pressure and the choice of initial antiplatelet therapy for minor ischemic stroke in real-world. Journal of clinical hypertension (Greenwich, Conn.), 2022, Volume: 24, Issue:4 Topics: Aged; Aspirin; Blood Pressure; Clopidogrel; Drug Therapy, Combination; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Treatment Outcome	2022
Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. JAMA internal medicine, 2022, 05-01, Volume: 182, Issue:5 Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke	2022
Cinnamon and Aspirin for Mild Ischemic Stroke or Transient Ischemic Attack: A Pilot Trial. Clinical therapeutics, 2022, Volume: 44, Issue:4 Topics: Aspirin; Cinnamomum zeylanicum; Clopidogrel; Constriction, Pathologic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome	2022
Prevalence of Drug metabolism and personalized therapy, 2021, 07-08, Volume: 37, Issue:1 Topics: Aged; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Hospitals; Humans; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Saudi Arabia	2021
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation. Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:1 Topics: Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Ischemic Stroke; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Treatment Outcome	2022
Dual antiplatelet treatment for minor acute ischemic stroke and high-risk transient ischemic attack: have we reached the limit of antithrombotic management? European journal of internal medicine, 2022, Volume: 100 Topics: Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke	2022
Circulating Microvesicles in Convalescent Ischemic Stroke Patients: A Contributor to High-On-Treatment Residual Platelet Reactivity? Frontiers in bioscience (Landmark edition), 2022, 05-16, Volume: 27, Issue:5 Topics: Blood Platelets; Cell-Derived Microparticles; Clopidogrel; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke	2022
No rebound effect after a course of clopidogrel in patients with acute TIA or minor stroke. Neurological research, 2022, Volume: 44, Issue:11 Topics: Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Recurrence; Stroke; Treatment Outcome	2022
Clopidogrel Resistance Among Ischemic Stroke Patients and Its Risk Factors in Indonesia. Acta medica academica, 2022, Volume: 51, Issue:1 Topics: Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Indonesia; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome	2022
Effect of body weight on bleeding events of aspirin in ischemic stroke or transient ischemic attack patients. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:10 Topics: Aspirin; Body Weight; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Stroke; Ticlopidine; Treatment Outcome	2022
Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack. Cerebrovascular diseases (Basel, Switzerland), 2022, Volume: 51, Issue:6 Topics: Case-Control Studies; Clopidogrel; DNA Methylation; Drug Resistance; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Recurrence; Risk Factors	2022
A study of microRNA-223 in evaluating platelet reactivity in patients with acute ischemic stroke. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022, Volume: 73, Issue:1 Topics: Adenosine Diphosphate; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Ischemic Stroke; MicroRNAs; Platelet Aggregation Inhibitors; Ticlopidine	2022
Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke. JAMA network open, 2022, 07-01, Volume: 5, Issue:7 Topics: Aged; Aspirin; Clopidogrel; Cohort Studies; Humans; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Prescriptions; Retrospective Studies; Stroke; United States	2022
Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention. PloS one, 2022, Volume: 17, Issue:7 Topics: Anticoagulants; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome	2022
Effectiveness and Safety of Clopidogrel vs Aspirin in Elderly Patients With Ischemic Stroke. Mayo Clinic proceedings, 2022, Volume: 97, Issue:8 Topics: Aged; Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome	2022
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China. Genetics research, 2022, Volume: 2022 Topics: Aged; Aspirin; Cerebral Infarction; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Middle Aged; Polymorphism, Genetic; Ticlopidine	2022
Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation. Journal of atherosclerosis and thrombosis, 2023, Aug-01, Volume: 30, Issue:8 Topics: Arteries; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome	2023
Use of dual antiplatelet therapy following posterior ischemic stroke. Journal of the neurological sciences, 2022, 12-15, Volume: 443 Topics: Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke	2022
Ten-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes of ischemic stroke in China: Analyses of a nationwide serial cross-sectional survey from 2005 to 2015. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:7 Topics: Atrial Fibrillation; Cardiovascular Diseases; China; Clopidogrel; Cross-Sectional Studies; Female; Heart Disease Risk Factors; Hospital Mortality; Hospitals; Humans; Ischemic Stroke; Male; Risk Factors; Sex Characteristics; Sex Factors; Stroke	2023
Safety and Efficacy of Baseline Antiplatelet Treatment in Patients Undergoing Mechanical Thrombectomy for Ischemic Stroke: Antiplatelets Before Mechanical Thrombectomy. Journal of vascular and interventional radiology : JVIR, 2023, Volume: 34, Issue:9 Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Intracranial Hemorrhages; Ischemic Stroke; Mechanical Thrombolysis; Stroke; Thrombectomy; Thrombolytic Therapy; Treatment Outcome	2023
Baseline P2Y12 reactivity, kidney function, and CYP2C19 genotype determine clopidogrel responsiveness in acute stroke. Scientific reports, 2023, 05-19, Volume: 13, Issue:1 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Kidney; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome	2023
Association between post-stroke smoking and stroke recurrence in first-ever ischemic stroke survivors: based on a 10-year prospective cohort. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:10 Topics: Clopidogrel; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Smoking; Stroke; Survivors; Treatment Outcome	2023
Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia-Reperfusion Injury in Rats. Pharmaceutical research, 2023, Volume: 40, Issue:7 Topics: Animals; Brain Ischemia; Clopidogrel; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Nanoparticles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Serum Albumin, Human	2023
Monitoring the Antiplatelet Therapy Efficacy in Patients with Acute Ischemic Stroke. Clinical laboratory, 2023, Jun-01, Volume: 69, Issue:6 Topics: Arteries; Aspirin; Clopidogrel; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke	2023
Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. European journal of clinical pharmacology, 2023, Volume: 79, Issue:8 Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhagic Stroke; Humans; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome	2023
Determinants and Temporal Trends of Dual Antiplatelet Therapy After Mild Noncardioembolic Stroke. Stroke, 2023, Volume: 54, Issue:10 Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome	2023
Comparative effectiveness of dual antiplatelet therapy versus monotherapy in patients with ischemic stroke. Neurosciences (Riyadh, Saudi Arabia), 2023, Volume: 28, Issue:4 Topics: Aspirin; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Ticlopidine; Treatment Outcome	2023
Ticagrelor vs Clopidogrel in Acute Myocardial Infarction Patients With a History of Ischemic Stroke. Mayo Clinic proceedings, 2023, Volume: 98, Issue:11 Topics: Aspirin; Clopidogrel; Humans; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Ticagrelor	2023
Dual energy CT in the management of antiplatelet therapy in patients with acute ischemic stroke for carotid obstruction. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2020, Volume: 26, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cerebral Hemorrhage; Clopidogrel; Female; Humans; Ischemic Stroke; Lysine; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome	2020
Antiplatelet agents for the secondary prevention of ischaemic stroke in patients with or without renal dysfunction. European journal of neurology, 2020, Volume: 27, Issue:3 Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Incidence; Ischemic Stroke; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Renal Dialysis; Risk Assessment; Secondary Prevention; Taiwan	2020
Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke. The International journal of neuroscience, 2020, Volume: 130, Issue:9 Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Tissue Plasminogen Activator	2020
Acute ischaemic stroke following cisplatin-based chemotherapy for testicular cancer. BMJ case reports, 2020, May-20, Volume: 13, Issue:5 Topics: Adult; Antineoplastic Agents; Aspirin; Cisplatin; Clopidogrel; Humans; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Testicular Neoplasms	2020
Efficacy and safety of clopidogrel and aspirin do not differ in patients with stable ischemic stroke. Journal of the Chinese Medical Association : JCMA, 2020, Volume: 83, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Ischemic Stroke; Male; Middle Aged; Proportional Hazards Models; Secondary Prevention	2020
Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance. European journal of clinical pharmacology, 2020, Volume: 76, Issue:11 Topics: Aged; Aspirin; Body Weight; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Drug Resistance; Female; Genotype; Humans; Ischemic Stroke; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Purinergic P2Y12	2020
Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study. BMJ open, 2020, 08-05, Volume: 10, Issue:8 Topics: Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Multicenter Studies as Topic; Observational Studies as Topic; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome	2020
Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations. Clinical drug investigation, 2020, Volume: 40, Issue:11 Topics: Aged; Asian People; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Loss of Function Mutation; Middle Aged; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ticagrelor	2020
Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel. Stroke and vascular neurology, 2021, Volume: 6, Issue:1 Topics: Aged; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Humans; Ischemic Stroke; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors	2021
Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients. Journal of thrombosis and thrombolysis, 2021, Volume: 52, Issue:1 Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Pneumonia; Retrospective Studies; Stroke; Treatment Outcome	2021
Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging. Scientific reports, 2020, 11-05, Volume: 10, Issue:1 Topics: Adult; Aged; Aspirin; Brain; Clopidogrel; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Treatment Outcome	2020
Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:7 Topics: Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Prediabetic State; Stroke; Treatment Outcome	2021
Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicent Circulation. Cardiovascular quality and outcomes, 2020, Volume: 13, Issue:11 Topics: Aged; Aspirin; Clopidogrel; Comparative Effectiveness Research; Databases, Factual; Dual Anti-Platelet Therapy; Female; Hemorrhagic Stroke; Humans; Ischemic Stroke; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Registries; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome	2020
CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:2 Topics: Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Databases, Factual; Drug Resistance; Female; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2021
Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1- and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Blood Platelets; Case-Control Studies; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Treatment Outcome	2021
Clopidogrel responder status is uninfluenced by CYP2C192 in Danish patients with stroke. PloS one, 2020, Volume: 15, Issue:12* Topics: Aged; Alleles; Clopidogrel; Cytochrome P-450 CYP2C19; Denmark; Female; Gene Frequency; Genotype; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Secondary Prevention	2020
Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2021, Volume: 16, Issue:4 Topics: Animals; Aspirin; Brain Ischemia; Clopidogrel; Inflammasomes; Ischemic Stroke; Isoindoles; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylbutyrates; Pyroptosis; Rats; Reperfusion Injury; Stroke; Ticagrelor	2021
Non-persistence with anti-platelet therapy and long-term mortality after ischemic stroke: A nationwide study. PloS one, 2021, Volume: 16, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Republic of Korea; Risk Assessment; Risk Factors; Stroke	2021
CYP2C19 Loss-of-Function Associated with First-Time Ischemic Stroke in Non-surgical Asymptomatic Carotid Artery Stenosis During Clopidogrel Therapy. Translational stroke research, 2022, Volume: 13, Issue:1 Topics: Aged; Carotid Stenosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Ischemic Attack, Transient; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Treatment Outcome	2022
Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study. The pharmacogenomics journal, 2021, Volume: 21, Issue:3 Topics: Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Databases, Factual; Endpoint Determination; Female; Genome-Wide Association Study; Homozygote; Humans; Ischemic Stroke; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Treatment Outcome	2021
Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome. The American journal of cardiology, 2021, 06-01, Volume: 148 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Case-Control Studies; Clopidogrel; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Heart Failure; Hemorrhage; Hospitalization; Humans; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; ST Elevation Myocardial Infarction; Stroke Volume; Ticagrelor; Treatment Outcome	2021
Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients. BMC neurology, 2021, Mar-09, Volume: 21, Issue:1 Topics: Aged; Aged, 80 and over; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Retrospective Studies; Secondary Prevention	2021
Platelet Function Monitoring Performed after Carotid Stenting during Endovascular Stroke Treatment Predicts Outcome. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:7 Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Databases, Factual; Disability Evaluation; Drug Monitoring; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome	2021
Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients. Journal of cardiovascular pharmacology, 2021, 09-01, Volume: 78, Issue:3 Topics: Aged; Aspirin; Clopidogrel; Disability Evaluation; Dual Anti-Platelet Therapy; Female; Functional Status; Hemorrhage; Humans; Infusions, Intravenous; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Retrospective Studies; Time Factors; Tirofiban; Treatment Outcome	2021
Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke. BMC neurology, 2021, Jun-24, Volume: 21, Issue:1 Topics: Aspirin; China; Clopidogrel; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Prospective Studies; Tirofiban	2021